Analyzing the factors that influence occult metastasis in oral tongue cancer

키워드

참고문헌 (47)

1. Ho CM, "Occult lymph node metastasis in small oral tongue cancers", Head Neck, 14, pp.359~363 (1992)
2. Grandi C, "Prognostic significance of lymphatic spread in head and neck carcinomas : therapeutic implications", Head Neck Surg, 8, pp.67~73 (1985)
3. Snow GB, "Prognostic factors of neck node metastasis", Clin Otolaryngol Allied Sci, 7, pp.185~192 (1982)
4. Whitehurst JO, "Surgical treatment of squamous cell carcinoma of the oral tongue : factors influencing survival", Arch Otolaryngol, 103, pp.212~215 (1977)
5. van den Brekel MW, "Cervical lymph node metastasis : assessment of radiologic criteria", Radiology, 177, pp.379~384 (1990)
6. Yuen AP, "Elective neck dissection versus observation in the treatment of early oral tongue carcinoma", Head Neck, 19, pp.583~588 (1997)
7. Werning JW, "Elective management of the clinically negative neck by otolaryngologists in patients with oral tongue cancer", Arch Otolaryngol Head Neck Surg, 129, pp.83~88 (2003)
8. Dünne AA, "Extent of surgical intervention in case of N0 neck in head and neck cancer patients : an analysis of data collection of 39 hospitals", Eur Arch Otorhinolaryngol, 261, pp.295~303 (2004)
9. Alitalo K, "Molecular mechanisms of lymphangiogenesis in health and disease", Cancer Cell, 1, pp.219~227 (2002)
10. Dadras SS, "Tumor lymphangiogenesis : a novel prognostic indicator for cutaneous melanoma metastasis and survival", Am J Pathol, 162, pp.1951~1960 (2003)
11. Karpanen T, "Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth", Cancer Res, 61, pp.1786~1790 (2001)
12. Pennacchietti S, "Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene", Cancer Cell, 3, pp.347~361 (2003)
13. Cao R, "Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action", Blood, 107, pp.3531~3536 (2006)
14. Kajiya K, "Hepatocyte growth factor promotes lymphatic vessel formation and function", EMBO J, 24, pp.2885~2895 (2005)
15. Zhang H, "ROR1 expression correlated with poor clinical outcome in human ovarian cancer", Sci Rep, 4, pp.5811~ (2014)
16. Green JL, "Ror receptor tyrosine kinases : orphans no more", Trends Cell Biol, 18, pp.536~544 (2008)
17. Daneshmanesh AH, "Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies", Leuk Lymphoma, 54, pp.843~850 (2013)
18. Zhang S, "ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth", PLoS One, 7, pp.e31127~ (2012)
19. Zhang S, "The onco-embryonic antigen ROR1 is expressed by a variety of human cancers", Am J Pathol, 181, pp.1903~1910 (2012)
20. Cui B, "Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis", Cancer Res, 73, pp.3649~3660 (2013)
21. Gentile A, "Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis", Cancer Res, 71, pp.3132~3141 (2011)
22. Faustino SE, "Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma", Int J Oral Maxillofac Surg, 37, pp.372~378 (2008)
23. Ma J, "Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma", Pathol Oncol Res, 19, pp.821~832 (2013)
24. Haddadin KJ, "Improved survival for patients with clinically T1", T2, N0 tongue tumors undergoing a prophylactic neck dissection, 1999, pp.21, 517~525
25. White D, "What is the preferred initial method of treatment for squamous carcinoma of the tongue?", Am J Surg, 140, pp.553~555 (1980)
26. O’Brien CJ, "The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx", Arch Otolaryngol Head Neck Surg, 126, pp.360~365 (2000)
27. Spiro RH, "Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth", Am J Surg, 152, pp.345~350 (1986)
28. Brown B, "Prognostic factors in mobile tongue and floor of mouth carcinoma", Cancer, 64, pp.1195~1202 (1989)
29. Mohit-Tabatabai MA, "Relation of thickness of floor of mouth stage I and II cancers to regional metastasis", Am J Surg, 152, pp.351~353 (1986)
30. Shaha AR, "Squamous carcinoma of the floor of the mouth", Am J Surg, 148, pp.455~459 (1984)
31. Franceschi D, "Improved survival in the treatment of squamous carcinoma of the oral tongue", Am J Surg, 166, pp.360~365 (1993)
32. Umeda M, "Lymph node metastasis in squamous cell carcinoma of the oral cavity : correlation between histologic features and the prevalence of metastasis", Head Neck, 14, pp.263~272 (1992)
33. Frierson HF Jr, "Prognostic factors in squamous cell carcinoma of the lower lip", Hum Pathol, 17, pp.346~354 (1986)
34. Ildstad ST, "Squamous cell carcinoma of the tongue : a comparison of the anterior two thirds of the tongue with its base", Am J Surg, 146, pp.456~461 (1983)
35. Nason RW, "A retrospective comparison of treatment outcome in the posterior and anterior tongue", Am J Surg, 172, pp.665~670 (1996)
36. Yii NW, "Management of the N0 neck in early cancer of the oral tongue", Clin Otolaryngol Allied Sci, 24, pp.75~79 (1999)
37. Duvvuri U, "Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx", Laryngoscope, 114, pp.2228~2234 (2004)
38. Dias FL, "Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth", Otolaryngol Head Neck Surg, 125, pp.23~29 (2001)
39. Hiratsuka H, "Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity", Cancer, 80, pp.351~356 (1997)
40. Zu X, "Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis", BJU Int, 98, pp.1090~1093 (2006)
41. Christensen J, "Beyond VEGF : targeting tumor growth and angiogenesis via alternative mechanisms", Adv Exp Med Biol, 610, pp.43~53 (2008)
42. Gherardi E, "Targeting MET in cancer : rationale and progress", Nat Rev Cancer, 12, pp.89~103 (2012)
43. Cortesina G, "Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases", Int J Cancer, 89, pp.286~292 (2000)
44. Chen YS, "Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan", J Oral Pathol Med, 33, pp.209~217 (2004)
45. Galeazzi E, "Detection of MET oncogene", hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas, 1997, pp.254(Suppl 1), S138~S143
46. Fukuda T, "Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a", Proc Natl Acad Sci U S A, 105, pp.3047~3052 (2008)
47. Yamaguchi T, "NKX2-1", TITF1, Cancer Cell, pp.2012, 21[DOI]

관련 논문AI추천